Previous close | 69.80 |
Open | 69.95 |
Bid | 70.04 x 1000 |
Ask | 71.16 x 800 |
Day's range | 70.47 - 71.81 |
52-week range | 52.90 - 75.31 |
Volume | |
Avg. volume | 248,817 |
Market cap | 3.536B |
Beta (5Y monthly) | 0.53 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.61 |
Earnings date | 02 May 2024 - 06 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 27 Dec 2013 |
1y target est | 75.60 |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The nausea-fighting brand is highlighting the cultural impact of barf bags and ushering them into a new era with a documentary, a limited-edition collection of upcycled bags and a custom wearable art piece made from vintage bagsTARRYTOWN, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- 1949 was a big year for barf, welcoming the invention of the barf bag and Dramamine®. Seventy-five years later, Dramamine, a Prestige Consumer Healthcare brand, thrives as the number one brand for motion sickness relief,
Key Insights The projected fair value for Prestige Consumer Healthcare is US$143 based on 2 Stage Free Cash Flow to...